Luminary Therapeutics is a pre-clinical cell therapy drug development company focused on creating the next generation of non-viral autologous cell therapies. Luminary employs a proprietary transposon technology to reduce the safety issues seen with viral based cell therapies. Luminary licenses cell therapy assets from notable academic centers for oncology and autoimmune indications allowing for significant advances over previous cell therapies.

Contact Luminary Therapeutics
Visit Website